Search filters
Filters
Clear All

Phase

  • 182
  • 151
  • 2
  • 188
  • 147
  • 17
  • 373
  • 1196
  • 568
  • 28
  • 44
  • 2
  • 1128
  • 1197
  • 5

Found 1202 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Assessing Drug Epetraborole in Patients with Mycobacterium avium Complex Lung Disease (MACrO2)

18 years - 99 years
All genders
Interventional
The purpose of this study is to learn about the effects of a study drug, Epetraborole, to assess the efficacy for treating refractory MAC. It will enroll patients over 18 years of age and will include the following: physical exams, CTs, medical history, ECGs, lung function tests, vital signs, safety …
Learn More

Stellate Ganglion Blockade During VT Ablation

18 years - 99 years
All genders
Interventional
The purpose of the study is to identify the effects that a “stellate ganglion blockade” has on the electrical and biochemical system of the heart. Eligible participants will be diagnosed ventricular tachycardia and are going to undergo an ablation procedure.
Learn More

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation after CABG

19 years - 99 years
All genders
Interventional
The purpose of the research is to compare two commonly used treatment strategies for managing atrial fibrillation after cardiac surgery. Patients 18 yrs. or older are randomized within 7 days after scheduled to undergo coronary artery bypass grafting (CABG), also known as bypass surgery. Only patients that undergo isolated CABG …
Learn More

Instylla HES Hypervascular Tumor Pivotal Study

22 years - 99 years
All genders
This research study is being conducted to determine if a new investigational device (Instylla Hydrogel Embolic system) can be used to treat tumors which have an extensive blood supply. This means that the tumors have many blood vessels feeding them. This product will be used to close blood vessels supplying …
Learn More

A Phase 2 Trial Of All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition In Recurrent IDH-Mutant Glioma

99 years or below
All genders
Phase 2
The purpose of this research study will be to evaluate the safety and effectiveness of two investigational drugs, All-trans retinoic acid (ATRA) and Retifanlimab (anti-PD1 monoclonal antibody), in treating recurrent IDH-mutant gliomas. Objective radiographic response (CR + PR + MR) using Response Assessment in Neuro-Oncology (RANO) criteria by measurable disease …
Learn More

ASSESSMENT OF TREATMENT WITH VISIBLE LIGHT ACTIVATED SYNTHETIC HYPERICIN OINTMENT IN MYCOSIS FUNGOIDES PATIENTS

18 years - 99 years
All genders
Phase 2
Interventional
The research study is being conducted to test the safety and efficacy of SGX301 (an investigational drug) in patients with mycosis fungoides in combination with light therapy using standard fluorescent lights. Eligible participants must have been diagnosed with mycosis fungoides, a form of Cutaneous T-cell Lymphoma. Participants will be asked …
Learn More

Antithrombotic Strategies in Hospitalized Adults with COVID-19

18 years - 99 years
All genders
Interventional
The purpose of this study is to compare the effectiveness of antithrombotic strategies for prevention of adverse outcomes in COVID-19 positive inpatients. Doctors use anticoagulation medicines, known as “blood thinners”, to lower the risk of blood clots forming in blood vessels (veins and arteries). The chance of blood clots in …
Learn More

Study of Itacitinib for the Prevention of Cytokine Release Syndrome Induced by Immune Effector Cell Therapy

18 years - 99 years
All genders
Phase 2
Interventional
The purpose of this study is to see if the Study drug works in the prevention of cytokine release syndrome. This is an open-label study, which means that both the participant and the study Doctor will know what study drug the participant is receiving. Participants will be in the study …
Learn More

Trial of anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for Multiple Myeloma Patients with Sub-Optimal Response After Autologous Hematopoietic Cell Transplantation and Maintenance Lenalidomide

99 years or below
All genders
We are doing this study to see if CAR T-cell therapy (bb2121) and maintenance therapy with the drug lenalidomide can help delay multiple myeloma from coming back.
Learn More

DECAMP 1 PLUS Proposal: Prediction of Lung Cancer Using Noninvasive Biomarkers

18 years - 99 years
All genders
The DECAMP 1 PLUS study will expand on previous early detection studies (DECAMP 1 and 2) to improve the efficiency of the diagnostic evaluation of patients with indeterminate pulmonary nodules. This study will investigate molecular, clinical and imaging features that may distinguish benign versus malignant disease among smokers with indeterminate …
Learn More
461 - 470 of 1202